Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review.

Strawn JR, Geracioti L, Rajdev N, Clemenza K, Levine A.

Expert Opin Pharmacother. 2018 Jul;19(10):1057-1070. doi: 10.1080/14656566.2018.1491966.

PMID:
30056792
2.

Discrete patterns of cortical thickness in youth with bipolar disorder differentially predict treatment response to quetiapine but not lithium.

Zhang W, Xiao Y, Sun H, Patino LR, Tallman MJ, Weber WA, Adler CM, Klein C, Strawn JR, Nery FG, Gong Q, Sweeney JA, Lui S, DelBello MP.

Neuropsychopharmacology. 2018 Jun 18. doi: 10.1038/s41386-018-0120-y. [Epub ahead of print]

PMID:
29946107
3.

Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder: Design, Definitions, and Ongoing Challenges for Child and Adolescent Psychopharmacology Research.

Strawn JR, Croarkin PE.

J Child Adolesc Psychopharmacol. 2018 Jun;28(5):363. doi: 10.1089/cap.2018.0012. Epub 2018 Apr 5. No abstract available.

PMID:
29620924
4.

The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A Meta-Analysis.

Strawn JR, Mills JA, Sauley BA, Welge JA.

J Am Acad Child Adolesc Psychiatry. 2018 Apr;57(4):235-244.e2. doi: 10.1016/j.jaac.2018.01.015. Epub 2018 Feb 8.

PMID:
29588049
5.

Behavioral interventions as a treatment for epilepsy: A multicenter randomized controlled trial.

Haut SR, Lipton RB, Cornes S, Dwivedi AK, Wasson R, Cotton S, Strawn JR, Privitera M.

Neurology. 2018 Mar 13;90(11):e963-e970. doi: 10.1212/WNL.0000000000005109. Epub 2018 Feb 14.

PMID:
29444968
6.

Antidepressant-Induced Activation in Children and Adolescents: Risk, Recognition and Management.

Luft MJ, Lamy M, DelBello MP, McNamara RK, Strawn JR.

Curr Probl Pediatr Adolesc Health Care. 2018 Feb;48(2):50-62. doi: 10.1016/j.cppeds.2017.12.001. Epub 2018 Jan 19.

PMID:
29358037
7.

Antidepressant Treatment Duration in Pediatric Depressive and Anxiety Disorders: How Long is Long Enough?

Hathaway EE, Walkup JT, Strawn JR.

Curr Probl Pediatr Adolesc Health Care. 2018 Feb;48(2):31-39. doi: 10.1016/j.cppeds.2017.12.002. Epub 2018 Jan 12.

PMID:
29337001
8.

Pharmacogenomic Testing in Child and Adolescent Psychiatry: An Evidence-Based Review.

Wehry AM, Ramsey L, Dulemba SE, Mossman SA, Strawn JR.

Curr Probl Pediatr Adolesc Health Care. 2018 Feb;48(2):40-49. doi: 10.1016/j.cppeds.2017.12.003. Epub 2018 Jan 8.

PMID:
29325731
9.

Individuation for a DSM-5 disorder: Adult separation anxiety.

Strawn JR, Dobson ET.

Depress Anxiety. 2017 Dec;34(12):1082-1084. doi: 10.1002/da.22703. No abstract available.

PMID:
29211944
10.

Suicidality in psychiatrically hospitalized children and adolescents: Demographics, treatment, and outcome.

Dobson ET, Keeshin BR, Wehry AM, Saldaña SN, Mukkamala LR, Sorter MT, DelBello MP, Blom TJ, Strawn JR.

Ann Clin Psychiatry. 2017 Nov;29(4):258-265.

PMID:
29069111
11.

The Generalized Anxiety Disorder 7-item scale in adolescents with generalized anxiety disorder: Signal detection and validation.

Mossman SA, Luft MJ, Schroeder HK, Varney ST, Fleck DE, Barzman DH, Gilman R, DelBello MP, Strawn JR.

Ann Clin Psychiatry. 2017 Nov;29(4):227-234A.

PMID:
29069107
12.

Buspirone in Children and Adolescents with Anxiety: A Review and Bayesian Analysis of Abandoned Randomized Controlled Trials.

Strawn JR, Mills JA, Cornwall GJ, Mossman SA, Varney ST, Keeshin BR, Croarkin PE.

J Child Adolesc Psychopharmacol. 2018 Feb;28(1):2-9. doi: 10.1089/cap.2017.0060. Epub 2017 Aug 28.

PMID:
28846022
13.

Use of Prazosin for Pediatric PTSD-Associated Nightmares and Sleep Disturbances: A Retrospective Chart Review.

Keeshin BR, Ding Q, Presson AP, Berkowitz SJ, Strawn JR.

Neurol Ther. 2017 Dec;6(2):247-257. doi: 10.1007/s40120-017-0078-4. Epub 2017 Jul 28.

14.

Acid-sensing T cell death associated gene-8 receptor expression in panic disorder.

Strawn JR, Vollmer LL, McMurray KMJ, Mills JA, Mossman SA, Varney ST, Schroeder HK, Sah R.

Brain Behav Immun. 2018 Jan;67:36-41. doi: 10.1016/j.bbi.2017.07.014. Epub 2017 Jul 20.

PMID:
28736033
15.

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update.

Kris MG, Gaspar LE, Chaft JE, Kennedy EB, Azzoli CG, Ellis PM, Lin SH, Pass HI, Seth R, Shepherd FA, Spigel DR, Strawn JR, Ung YC, Weyant M.

J Clin Oncol. 2017 Sep 1;35(25):2960-2974. doi: 10.1200/JCO.2017.72.4401. Epub 2017 Apr 24. Review.

PMID:
28437162
16.

Placebo Response in Pediatric Anxiety Disorders: Results from the Child/Adolescent Anxiety Multimodal Study.

Strawn JR, Dobson ET, Mills JA, Cornwall GJ, Sakolsky D, Birmaher B, Compton SN, Piacentini J, McCracken JT, Ginsburg GS, Kendall PC, Walkup JT, Albano AM, Rynn MA.

J Child Adolesc Psychopharmacol. 2017 Aug;27(6):501-508. doi: 10.1089/cap.2016.0198. Epub 2017 Apr 6.

17.

Extended Release Guanfacine in Pediatric Anxiety Disorders: A Pilot, Randomized, Placebo-Controlled Trial.

Strawn JR, Compton SN, Robertson B, Albano AM, Hamdani M, Rynn MA.

J Child Adolesc Psychopharmacol. 2017 Feb;27(1):29-37. doi: 10.1089/cap.2016.0132. Epub 2017 Feb 6.

18.

Antidepressant Prescribing by Pediatricians: A Mixed-Methods Analysis.

Tulisiak AK, Klein JA, Harris E, Luft MJ, Schroeder HK, Mossman SA, Varney ST, Keeshin BR, Cotton S, Strawn JR.

Curr Probl Pediatr Adolesc Health Care. 2017 Jan;47(1):15-24. doi: 10.1016/j.cppeds.2016.11.009. Epub 2017 Jan 2.

19.

Primary Pediatric Care Psychopharmacology: Focus on Medications for ADHD, Depression, and Anxiety.

Strawn JR, Dobson ET, Giles LL.

Curr Probl Pediatr Adolesc Health Care. 2017 Jan;47(1):3-14. doi: 10.1016/j.cppeds.2016.11.008. Epub 2016 Dec 30. Review.

20.

White matter volumes in youth offspring of bipolar parents.

Nery FG, Norris M, Eliassen JC, Weber WA, Blom TJ, Welge JA, Barzman DA, Strawn JR, Adler CM, Strakowski SM, DelBello MP.

J Affect Disord. 2017 Feb;209:246-253. doi: 10.1016/j.jad.2016.11.023. Epub 2016 Nov 25.

PMID:
27936454
21.

Familial risk for bipolar disorder is not associated with impaired peroxisomal function: Dissociation from docosahexaenoic acid deficits.

McNamara RK, Moser AB, Jones RI, Jandacek R, Patino LR, Strawn JR, Strakowski SM, DelBello MP.

Psychiatry Res. 2016 Dec 30;246:803-807. doi: 10.1016/j.psychres.2016.10.042. Epub 2016 Oct 25.

22.

Neurofunctional Differences Among Youth With and at Varying Risk for Developing Mania.

Welge JA, Saliba LJ, Strawn JR, Eliassen JC, Patino LR, Adler CM, Weber W, Schneider MR, Barzman DH, Strakowski SM, DelBello MP, McNamara RK.

J Am Acad Child Adolesc Psychiatry. 2016 Nov;55(11):980-989. doi: 10.1016/j.jaac.2016.08.006. Epub 2016 Sep 13.

PMID:
27806866
23.

fMRI brain activation changes following treatment of a first bipolar manic episode.

Strakowski SM, Fleck DE, Welge J, Eliassen JC, Norris M, Durling M, Komoroski RA, Chu WJ, Weber W, Dudley JA, Blom TJ, Stover A, Klein C, Strawn JR, DelBello MP, Lee JH, Adler CM.

Bipolar Disord. 2016 Sep;18(6):490-501. doi: 10.1111/bdi.12426. Epub 2016 Sep 19.

24.

Pharmacologic Treatment of Pediatric Anxiety Disorders.

Hussain FS, Dobson ET, Strawn JR.

Curr Treat Options Psychiatry. 2016 Jun;3(2):151-160. Epub 2016 Apr 22.

25.

Psychopharmacologic Management of Anxiety in an Adolescent with Congenital Long QT Syndrome.

Minton TB, Rosing J, Spar DS, Strawn JR, Garcia-Delgar B, Coffey BJ.

J Child Adolesc Psychopharmacol. 2016 Jun;26(5):485-9. doi: 10.1089/cap.2016.29109.bjc. Epub 2016 Jun 10. No abstract available.

PMID:
27285068
26.

Comorbid Anxiety and Depressive Symptoms in Children and Adolescents: A Systematic Review and Analysis.

Melton TH, Croarkin PE, Strawn JR, McClintock SM.

J Psychiatr Pract. 2016 Mar;22(2):84-98. doi: 10.1097/PRA.0000000000000132. Review.

PMID:
27138077
27.

Placebo Response in Pediatric Anxiety Disorders: Implications for Clinical Trial Design and Interpretation.

Dobson ET, Strawn JR.

J Child Adolesc Psychopharmacol. 2016 Oct;26(8):686-693. Epub 2016 Mar 30.

28.

Neural Function Before and After Mindfulness-Based Cognitive Therapy in Anxious Adolescents at Risk for Developing Bipolar Disorder.

Strawn JR, Cotton S, Luberto CM, Patino LR, Stahl LA, Weber WA, Eliassen JC, Sears R, DelBello MP.

J Child Adolesc Psychopharmacol. 2016 May;26(4):372-9. doi: 10.1089/cap.2015.0054. Epub 2016 Jan 19.

29.

Pharmacotherapy for Pediatric Generalized Anxiety Disorder: A Systematic Evaluation of Efficacy, Safety and Tolerability.

Dobson ET, Strawn JR.

Paediatr Drugs. 2016 Feb;18(1):45-53. doi: 10.1007/s40272-015-0153-1. Review.

30.

Adolescents with or at ultra-high risk for bipolar disorder exhibit erythrocyte docosahexaenoic acid and eicosapentaenoic acid deficits: a candidate prodromal risk biomarker.

McNamara RK, Jandacek R, Tso P, Blom TJ, Welge JA, Strawn JR, Adler CM, Strakowski SM, DelBello MP.

Early Interv Psychiatry. 2016 Jun;10(3):203-11. doi: 10.1111/eip.12282. Epub 2015 Oct 20.

31.

First-episode bipolar disorder is associated with erythrocyte membrane docosahexaenoic acid deficits: Dissociation from clinical response to lithium or quetiapine.

McNamara RK, Jandacek R, Tso P, Blom TJ, Welge JA, Strawn JR, Adler CM, DelBello MP, Strakowski SM.

Psychiatry Res. 2015 Dec 15;230(2):447-53. doi: 10.1016/j.psychres.2015.09.035. Epub 2015 Oct 9.

32.

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

Masters GA, Temin S, Azzoli CG, Giaccone G, Baker S Jr, Brahmer JR, Ellis PM, Gajra A, Rackear N, Schiller JH, Smith TJ, Strawn JR, Trent D, Johnson DH; American Society of Clinical Oncology Clinical Practice.

J Clin Oncol. 2015 Oct 20;33(30):3488-515. doi: 10.1200/JCO.2015.62.1342. Epub 2015 Aug 31. Erratum in: J Clin Oncol. 2016 Apr 10;34(11):1287.

33.

Childhood trauma in patients with self-reported stress-precipitated seizures.

Lee I, Strawn JR, Dwivedi AK, Walters M, Fleck A, Schwieterman D, Haut SR, Polak E, Privitera M.

Epilepsy Behav. 2015 Oct;51:210-4. doi: 10.1016/j.yebeh.2015.07.019. Epub 2015 Aug 24.

PMID:
26295447
34.

Acid-base dysregulation and chemosensory mechanisms in panic disorder: a translational update.

Vollmer LL, Strawn JR, Sah R.

Transl Psychiatry. 2015 May 26;5:e572. doi: 10.1038/tp.2015.67. Review.

35.

Assessment and treatment of anxiety disorders in children and adolescents.

Wehry AM, Beesdo-Baum K, Hennelly MM, Connolly SD, Strawn JR.

Curr Psychiatry Rep. 2015 Jul;17(7):52. doi: 10.1007/s11920-015-0591-z. Review.

36.

Neurostructural abnormalities in pediatric anxiety disorders.

Strawn JR, Hamm L, Fitzgerald DA, Fitzgerald KD, Monk CS, Phan KL.

J Anxiety Disord. 2015 May;32:81-8. doi: 10.1016/j.janxdis.2015.03.004. Epub 2015 Mar 17.

37.

Elevated salivary alpha amylase in adolescent sexual abuse survivors with posttraumatic stress disorder symptoms.

Keeshin BR, Strawn JR, Out D, Granger DA, Putnam FW.

J Child Adolesc Psychopharmacol. 2015 May;25(4):344-50. doi: 10.1089/cap.2014.0034. Epub 2015 Mar 24.

38.

A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder.

Strawn JR, Prakash A, Zhang Q, Pangallo BA, Stroud CE, Cai N, Findling RL.

J Am Acad Child Adolesc Psychiatry. 2015 Apr;54(4):283-93. doi: 10.1016/j.jaac.2015.01.008. Epub 2015 Jan 29.

PMID:
25791145
39.

Neurobiology of Pediatric Anxiety Disorders.

Strawn JR, Dominick KC, Patino LR, Doyle CD, Picard LS, Phan KL.

Curr Behav Neurosci Rep. 2014 Sep 1;1(3):154-160.

40.

The effects of lacosamide on depression and anxiety in patients with epilepsy.

Moseley BD, Cole D, Iwuora O, Strawn JR, Privitera M.

Epilepsy Res. 2015 Feb;110:115-8. doi: 10.1016/j.eplepsyres.2014.12.007. Epub 2014 Dec 15.

PMID:
25616463
41.

Mindfulness-based cognitive therapy for youth with anxiety disorders at risk for bipolar disorder: a pilot trial.

Cotton S, Luberto CM, Sears RW, Strawn JR, Stahl L, Wasson RS, Blom TJ, Delbello MP.

Early Interv Psychiatry. 2016 Oct;10(5):426-34. doi: 10.1111/eip.12216. Epub 2015 Jan 13.

PMID:
25582800
42.

Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis.

Strawn JR, Welge JA, Wehry AM, Keeshin B, Rynn MA.

Depress Anxiety. 2015 Mar;32(3):149-57. doi: 10.1002/da.22329. Epub 2014 Nov 28. Review.

43.

Neurostructural impact of co-occurring anxiety in pediatric patients with major depressive disorder: a voxel-based morphometry study.

Wehry AM, McNamara RK, Adler CM, Eliassen JC, Croarkin P, Cerullo MA, DelBello MP, Strawn JR.

J Affect Disord. 2015 Jan 15;171:54-9. doi: 10.1016/j.jad.2014.09.004. Epub 2014 Sep 16.

PMID:
25285899
44.

Cortical surface anatomy in pediatric patients with generalized anxiety disorder.

Strawn JR, John Wegman C, Dominick KC, Swartz MS, Wehry AM, Patino LR, Strakowski SM, Adler CM, Eliassen JC, DelBello MP.

J Anxiety Disord. 2014 Oct;28(7):717-23. doi: 10.1016/j.janxdis.2014.07.012. Epub 2014 Aug 12.

PMID:
25155256
45.

Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization.

Saldaña SN, Keeshin BR, Wehry AM, Blom TJ, Sorter MT, DelBello MP, Strawn JR.

Pharmacotherapy. 2014 Aug;34(8):836-44. doi: 10.1002/phar.1453. Epub 2014 Jul 3.

46.

Bipolar I disorder and major depressive disorder show similar brain activation during depression.

Cerullo MA, Eliassen JC, Smith CT, Fleck DE, Nelson EB, Strawn JR, Lamy M, DelBello MP, Adler CM, Strakowski SM.

Bipolar Disord. 2014 Nov;16(7):703-12. doi: 10.1111/bdi.12225. Epub 2014 Jul 3.

47.

Effects of fish oil supplementation on prefrontal metabolite concentrations in adolescents with major depressive disorder: a preliminary 1H MRS study.

McNamara RK, Jandacek R, Rider T, Tso P, Chu WJ, Weber WA, Welge JA, Strawn JR, Adler CM, DelBello MP.

Nutr Neurosci. 2016 May;19(4):145-55. doi: 10.1179/1476830514Y.0000000135. Epub 2016 Mar 2.

48.

Detection and Treatment of Long-Chain Omega-3 Fatty Acid Deficiency in Adolescents with SSRI-Resistant Major Depressive Disorder.

McNamara RK, Strimpfel J, Jandacek R, Rider T, Tso P, Welge JA, Strawn JR, Delbello MP.

PharmaNutrition. 2014 Apr 1;2(2):38-46.

49.

Psychological and pharmacologic treatment of youth with posttraumatic stress disorder: an evidence-based review.

Keeshin BR, Strawn JR.

Child Adolesc Psychiatr Clin N Am. 2014 Apr;23(2):399-411, x. doi: 10.1016/j.chc.2013.12.002. Epub 2014 Feb 16. Review.

PMID:
24656587
50.

Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial.

Alaka KJ, Noble W, Montejo A, Dueñas H, Munshi A, Strawn JR, Lenox-Smith A, Ahl J, Bidzan L, Dorn B, Ball S.

Int J Geriatr Psychiatry. 2014 Sep;29(9):978-86. doi: 10.1002/gps.4088. Epub 2014 Feb 20.

Supplemental Content

Loading ...
Support Center